Furthermore, immunofluorescence assay showed that STAT3 was typically expressed in the cytoplasm of A172, LN428, and U251 glioma cells, but its expression decreased after treatment with BY4003 and BY4008 (Fig. 7A). The gene discussed is STAT3; the disease is central nervous system cancer.